Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 Mechanism of action  




2 Research  




3 References  




4 External links  













HT-0712






●تۆرکجه
 ●Српски / srpski
 ●Srpskohrvatski / српскохрватски
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

HT-0712
Clinical data
Other namesHT-0712, IPL 455,903
ATC code
  • None
Identifiers

  • (3S,5S)-5-(3-(Cyclopentyloxy)-4-methoxyphenyl)-3-(3-methylbenzyl)piperidin-2-one

CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC25H31NO3
Molar mass393.527 g·mol−1
3D model (JSmol)

  • O=C3NC[C@H](c2cc(OC1CCCC1)c(OC)cc2)C[C@H]3Cc4cccc(c4)C

  • InChI=1S/C25H31NO3/c1-17-6-5-7-18(12-17)13-20-14-21(16-26-25(20)27)19-10-11-23(28-2)24(15-19)29-22-8-3-4-9-22/h5-7,10-12,15,20-22H,3-4,8-9,13-14,16H2,1-2H3,(H,26,27)/t20-,21-/m1/s1 checkY

  • Key:ABEJDMOBAFLQNJ-NHCUHLMSSA-N checkY

  (verify)

HT-0712, also known as IPL-455903,[1] is an experimental cognitive enhancing drug (nootropic) which is currently undergoing clinical trials. It is currently being licensed by Helicon Therapeutics in San Diego, California. It was originally discovered and tested as part of a preclinical anti-inflammatory program by Inflazyme Pharmaceuticals.[2]

Mechanism of action

[edit]

HT-0712 appears to act as a PDE4 inhibitor, thereby increasing cAMP levels. When cAMP levels are increased in neurons, this may trigger the activation of cAMP response element-binding proteins (CREB). CREBs are transcription factors involved in the formation of long-term memory.[2]

The side effects of the drug are not yet fully known.

Research

[edit]

A 2014 study found that HT-0712 significantly boosted memory formation in mice. Data also indicated that HT-0712 may be effective to treat age-associated memory impairment in humans.[3]

References

[edit]
  1. ^ Giembycz MA (October 2008). "Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking?". British Journal of Pharmacology. 155 (3): 288–290. doi:10.1038/bjp.2008.297. PMC 2567889. PMID 18660832.
  • ^ a b MacDonald E, Van der Lee H, Pocock D, Cole C, Thomas N, VandenBerg PM, et al. (2007). "A novel phosphodiesterase type 4 inhibitor, HT-0712, enhances rehabilitation-dependent motor recovery and cortical reorganization after focal cortical ischemia". Neurorehabilitation and Neural Repair. 21 (6): 486–496. doi:10.1177/1545968307305521. PMID 17823313.
  • ^ Peters M, Bletsch M, Stanley J, Wheeler D, Scott R, Tully T (December 2014). "The PDE4 inhibitor HT-0712 improves hippocampus-dependent memory in aged mice". Neuropsychopharmacology. 39 (13): 2938–2948. doi:10.1038/npp.2014.154. PMC 4229572. PMID 24964813.
    • [edit]

    Retrieved from "https://en.wikipedia.org/w/index.php?title=HT-0712&oldid=1227523500"
    Categories: 
    ●Drugs not assigned an ATC code
     ●Lactams
     ●Nootropics
     ●PDE4 inhibitors
     ●Phenol ethers
     ●Cyclopentyl compounds
     ●3-Tolyl compounds
     Hidden categories: 
    ●Articles with short description
     ●Short description matches Wikidata
     ●Articles without EBI source
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●Drugs with no legal status
      


    ●This page was last edited on 6 June 2024, at 07:26 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki